Dr. Karlen studies several aspects of Hodgkin lymphoma, a type of cancer that affects the lymphatic system. His research helps differentiate normal tissue responses from cancer relapses in children undergoing chemotherapy, ensuring accurate diagnoses. He also investigates the role of imaging techniques in assessing cancer stages and the impacts of tumors on immune responses. Additionally, Dr. Karlen looks at ways to improve treatment strategies for patients with associated conditions, particularly in pediatric oncology.
Key findings
In a study of 1,178 patients with Hodgkin lymphoma, 29.7% had hypodense volumes linked to worse symptoms and a lower five-year disease-free survival rate of 79.6%, compared to 89.7% for those without these volumes.
Out of 291 children analyzed, only 98 showed clear differentiation between rebound thymic hyperplasia and thymic relapse without a biopsy, which aids in treatment planning post-chemotherapy.
In a trial regarding children with Hodgkin lymphoma, patients treated without radiotherapy after chemotherapy achieved a survival rate of 96.3% over ten years, showcasing the potential to avoid radiation's long-term risks.
Frequently asked questions
Does Dr. Karlen study Hodgkin lymphoma?
Yes, Dr. Karlen focuses extensively on Hodgkin lymphoma, particularly its diagnosis, treatment options, and outcomes for pediatric patients.
What treatments has Dr. Karlen researched for Hodgkin lymphoma?
He has researched the potential of omitting radiation therapy in favor of chemotherapy alone for children in complete remission, which has shown promising long-term survival rates.
Is Dr. Karlen's work relevant to children with cancer?
Absolutely, much of his research concentrates on pediatric populations, aiming to improve diagnostics and treatment strategies specifically for young cancer patients.
What imaging techniques does Dr. Karlen study?
He studies the effectiveness of various imaging techniques that assist in accurately staging Hodgkin lymphoma in children, which can lead to better-targeted therapies.
How does Dr. Karlen's research help in cancer treatment decisions?
His findings provide crucial information that helps doctors make informed decisions regarding treatment plans and management of Hodgkin lymphoma, which can enhance patient outcomes.
Publications in plain English
Hodgkin lymphoma: hypodense lesions in mediastinal masses.
2024
Scientific reports
Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A +26 more
Plain English This study looked at patients with Hodgkin lymphoma and how certain masses in their chest, called hypodense volumes (HDV), appear on CT scans. Out of 1,178 patients, 29.7% had these HDVs, which were usually linked to larger tumors and more severe symptoms like fever and weight loss. Those with larger HDVs had a lower chance of staying free from disease for five years (79.6% vs. 89.7%) compared to those with smaller or no HDVs.
Who this helps: This research benefits doctors treating Hodgkin lymphoma patients, as it provides important information about tumor characteristics that can guide treatment decisions.
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
2023
Pediatric blood & cancer
Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D +23 more
Plain English This study looked at how to tell the difference between rebound thymic hyperplasia (RTH), which is a normal response after chemotherapy, and thymic relapse (LR) of cancer in children with Hodgkin lymphoma. Researchers analyzed the medical images of 291 patients and found that 133 had growth in the thymus, but only 98 could be clearly identified as either RTH or LR without a biopsy. They discovered that if other tumors were growing nearby, it was likely a cancer relapse, while a stand-alone thymic growth indicated RTH.
Who this helps: This helps doctors diagnose and make treatment decisions for children with Hodgkin lymphoma.
Fractures in the Setting of Constriction Band Syndrome: A Case Series of Three Patients with Extremity Fractures at the Site of a Constriction Band.
2022
Children (Basel, Switzerland)
Cho Y, Qubain L, Esparza M, Karlen J, Schaub T +1 more
Plain English This study looked at three patients who had fractures in their arms or legs caused by a condition called constriction band syndrome (CBS), where tight bands of tissue restrict blood flow and can cause other problems. The study found that two of the patients healed well after having their fractures treated with a specific type of rod called a k-wire, which helped support their healing. Understanding how to manage fractures in CBS patients is important because it helps improve their recovery and ensures they receive the right care.
Who this helps: This helps patients with constriction band syndrome and their doctors.
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial.
2021
Pediatric blood & cancer
Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R +29 more
Plain English The study assessed how well imaging techniques can identify involvement of Waldeyer's ring (a group of lymphoid tissues in the throat) in young patients with Hodgkin lymphoma. Out of 1,752 patients reviewed, only 4 out of 14 who were suspected to have WR involvement based on physical exams were confirmed by imaging techniques. This matters because using advanced imaging can improve the accuracy of cancer staging, leading to better-targeted treatments for young patients.
Who this helps: This helps patients with Hodgkin lymphoma and their doctors in determining the best treatment approach.
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.
2020
Nature immunology
Diskin B, Adam S, Cassini MF, Sanchez G, Liria M +30 more
Plain English This study explored how a protein called PD-L1 on T cells affects the immune response to cancer. Researchers found that when T cells express PD-L1, they can prevent the activation of other immune cells and promote an environment that helps tumors grow. Specifically, this mechanism involves altering neighboring T cells and immune cells called macrophages, which weakens the body’s ability to fight the tumor.
Who this helps: This research benefits cancer patients by providing insights into how tumors evade the immune system.
Barilla RM, Diskin B, Caso RC, Lee KB, Mohan N +25 more
Plain English Researchers studied how certain immune cells in pancreatic cancer influence other immune cells and affect tumor growth. They found that a specific type of immune cell, called CD11bCD103 dendritic cells, can lead to the development of regulatory T cells that help tumors grow by suppressing immune responses. In their experiments, they observed that this same pattern exists in human pancreatic cancer cases, which was associated with lower chances of patient survival.
Who this helps: This research helps patients with pancreatic cancer by providing insights that could improve future treatments.
Syndromic Scoliosis: National Trends in Surgical Management and Inpatient Hospital Outcomes: A 12-Year Analysis.
2019
Spine
Chung AS, Renfree S, Lockwood DB, Karlen J, Belthur M
Plain English This study looked at how surgical procedures for kids with syndromic scoliosis (curvature of the spine linked to other health conditions) have changed over 12 years, comparing them to kids with regular scoliosis. It found that 1,071 kids with syndromic scoliosis faced more complications during surgery—2.7% had major issues compared to 1.0% for regular scoliosis patients, and 41.0% experienced minor complications against 28.5% for regular scoliosis patients. Understanding these findings is important as it highlights that kids with syndromic scoliosis are at higher risk during surgery, which could impact how doctors plan surgeries for these patients.
Who this helps: This helps doctors and healthcare providers who treat patients with scoliosis, especially those with additional syndromic conditions.
F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
2018
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D +22 more
Plain English This study looked at how kids with Hodgkin lymphoma respond to chemotherapy, specifically focusing on skeletal (bone) involvement. Out of 1,068 patients, 139 showed bone involvement, and 73% of them had no signs of disease in their bones after two cycles of treatment. This is important because it shows that the current measures used to track bone response in these patients are effective and provides insight into which patients might respond better to treatment.
Who this helps: This helps pediatric cancer patients and their doctors better understand treatment outcomes and response to therapy.
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
2016
PloS one
Kluge R, Chavdarova L, Hoffmann M, Kobe C, Malkowski B +14 more
Plain English This research focused on how consistently doctors agree when using the five-point Deauville scale to evaluate the response of Hodgkin lymphoma patients to chemotherapy after two treatment cycles. The study found that when five expert readers assessed 100 PET scans of children with Hodgkin lymphoma, they only agreed on the scores 42% of the time, improving to 60% when simplifying the scale. This inconsistency matters because it can lead to different treatment decisions based on how the scans are interpreted.
Who this helps: This helps doctors who assess treatment responses in young Hodgkin lymphoma patients.
Plain English This research looked for gravitational waves linked to 223 gamma-ray bursts (GRBs) that were observed between 2005 and 2010. Scientists found no gravitational wave signals related to these bursts, meaning they couldn’t confirm a connection between the bursts and the expected gravitational waves from merging stars. They also determined that the sources of these GRBs are likely at least 12 to 22 million light-years away.
Who this helps: This research benefits astronomers and physicists studying cosmic events and gravitational waves.
Plain English This study looked for a background noise of gravitational waves created by various sources in the universe using data from the LIGO and Virgo detectors, from 2009 to 2010. The researchers found no signs of this background noise, but they established new upper limits on its energy density. Specifically, they reported that in the frequency range of 41.5-169.25 Hz, the gravitational wave energy density is less than 5.6 × 10^-6, and in the 600-1000 Hz range, it is 2.5 times lower than previously measured, leading to better understanding of gravitational waves.
Who this helps: This benefits scientists studying the universe's evolution and gravitational waves.
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
2013
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Dörffel W, Rühl U, Lüders H, Claviez A, Albrecht M +11 more
Plain English This study looked at treating children and teenagers with Hodgkin lymphoma, specifically whether radiation therapy (RT) can be skipped for those who are clear of cancer after chemotherapy. Researchers found that after ten years, 96.3% of patients were still alive, and 88.2% were free of disease progression if they had no RT, while patients who did need RT had lower success rates depending on their cancer stage. This matters because it shows that many young patients can avoid the long-term risks associated with radiation, while still having excellent chances of recovery.
Who this helps: This research benefits young cancer patients and their families by reducing their treatment burden and long-term health risks.
Fine-needle aspiration cytology of angiomatoid malignant fibrous histiocytoma.
2005
Diagnostic cytopathology
Lemos MM, Karlen J, Tani E
Plain English This study looked at a rare type of tumor called angiomatoid malignant fibrous histiocytoma (AMFH), which mainly affects children and young adults. Researchers examined tissue samples from two patients and found specific cell types that can help doctors identify this tumor before surgery. The findings suggest that with the right tests and patient information, doctors can accurately diagnose AMFH before performing surgery.
Who this helps: This helps doctors and medical professionals who treat patients with this rare tumor.
[Decompressive craniotomy in severe craniocerebral trauma following unsuccessful treatment with barbiturates].
1987
Neurochirurgia
Karlen J, Stula D
Plain English In this study, researchers examined the intracranial pressure of 51 patients who had severe brain injuries. They found that 41% of the patients had normal pressure and improved without much treatment, while 28 patients had high pressure that didn't respond to standard treatments. For the 7 patients who still didn't improve, a surgical procedure called decompressive craniotomy was required, and the study discusses their treatment and outcomes.
Who this helps: This helps doctors determine the best treatment options for patients with severe brain injuries.